The liver enzyme serum alanine aminotransferase (ALT) is commonly used as a surrogate marker of suspected NAFLD and is considered as the best screening tool of pediatric NAFLD up to now [8, 20]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.